Welcome to our dedicated page for Jefferson Capital SEC filings (Ticker: JCAP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Jefferson Capital, Inc. (NASDAQ: JCAP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its activities as an analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts. These SEC filings cover its operations in the United States, Canada, the United Kingdom and Latin America, and describe its work with secured and unsecured consumer receivables originated by banks, non-bank consumer lenders, auto finance companies, utilities, telecommunications providers, credit card issuers and fintech origination platforms.
On this page, you can review Jefferson Capital’s current reports on Form 8-K, which disclose material events such as quarterly financial results, asset purchase agreements and amendments to its senior secured revolving credit facility. For example, Form 8-K filings describe the asset purchase agreement to acquire a credit card receivables portfolio from affiliates of Bluestem Brands and the amendment that increased aggregate commitments and extended the maturity of the company’s revolving credit facility.
In addition to 8-Ks, Jefferson Capital’s registration statements, such as Form S-1, and periodic reports on Form 10-Q and other filings discuss risk factors, leverage, liquidity, capital resources and non-GAAP financial measures used by management. These documents explain how the company funds portfolio purchases, manages its credit facility covenants and evaluates collections and estimated remaining collections on its receivables portfolios.
Stock Titan’s SEC filings page for JCAP provides real-time access to new filings as they are posted to EDGAR, along with AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify disclosures on portfolio acquisitions, financing arrangements, quarterly and annual results, and other regulatory information relevant to Jefferson Capital’s receivables management business.
Zellmann Mark Joseph reported acquisition or exercise transactions in this Form 4 filing.
Jefferson Capital executive Mark Joseph Zellmann, President US Business Lines, received two grants of stock options, each covering 12,500 shares of common stock. The Form 4 classifies these as compensation-related grants or awards rather than open-market purchases.
The reported transaction prices for the option grants are $20.13 and $34.13 per share, with both option series expiring on
Jefferson Capital, Inc. director Susan E. Atkins has filed an initial statement of beneficial ownership, showing two direct stock option positions over the company’s common stock. Each option relates to 25,000 underlying shares, with exercise prices of
Jefferson Capital, Inc. director Pierce James Manfred filed an initial ownership report showing two stock option awards. Each option covers 25,000 shares of common stock, with exercise prices of
Jefferson Capital, Inc. reported a board change on March 18, 2026. Christopher Giles resigned as a Class II director effective immediately to focus on other professional commitments, and the company stated his resignation was not due to any disagreement over operations, policies, or practices.
The board appointed Susan Atkins as a Class II director and James Pierce as a Class III director, with terms ending at the 2027 and 2028 annual meetings, respectively. Each new director received an option to purchase 50,000 common shares, half at fair market value on the grant date and half at fair market value plus $14.00, vesting in equal annual installments over three years, subject to continued board service.
Jefferson Capital, Inc. filed an update to its 2025 executive compensation disclosure. On March 11, 2025, the board approved 2025 annual cash bonuses for President and CEO David Burton at 100% of his target and for President of U.S. Business Lines Mark Zellmann at 86% of his target, based on 2025 performance. The company also finalized performance-based commissions for Chief Commercial Officer Penelope Person for 2025 and has now incorporated these amounts into its 2025 Summary Compensation Table originally included in its January 5, 2026 prospectus. After these additions, 2025 non-equity incentive plan compensation was $382,884 for Burton, $247,202 for Zellmann, and $208,864 for Person, bringing their 2025 total compensation to $3,795,973, $1,062,184, and $633,060, respectively.
OROS JOHN J reported acquisition or exercise transactions in this Form 4 filing.
Jefferson Capital director John J. Oros received two stock option grants as compensation. On March 11, 2026, he was awarded options covering 25,000 shares of common stock at $20.78 per share and another 25,000 shares at $34.78 per share, each expiring on March 10, 2036.
The filing shows 25,000 derivative shares reported as beneficially owned following each transaction entry, indicating these are new grants rather than sales. A footnote explains the options vest in three equal annual installments, subject to Mr. Oros continuing to serve through each vesting date.
Jefferson Capital, Inc. files its annual report describing a global business that buys and services nonperforming consumer receivables across the U.S., Canada, the U.K. and Latin America. The company purchases charged-off and distressed portfolios, then collects through legal and call-center channels and third-party agencies.
In June 2025, Jefferson Capital completed an IPO in which selling shareholders sold 10,875,000 shares at $15.00 per share and the company issued 625,000 shares, generating net proceeds of $4.5 million. As of June 30, 2025, common stock held by non-affiliates had an aggregate market value of $316.0 million, and as of March 12 there were 55,329,124 shares outstanding.
The report highlights a $196.3 million purchase of Bluestem credit card assets, with estimated remaining collections of $295.6 million, and discusses prior Conn’s portfolio purchases. Extensive risk disclosures cover economic downturns, concentration in a few large sellers, regulatory and litigation exposure, international and tax changes, reliance on outsourcing (including operations in Mumbai), and growing cybersecurity and data privacy obligations under regimes such as CFPB rules, GDPR and CCPA.
Jefferson Capital, Inc. reported strong fourth quarter and full year 2025 results, highlighted by record performance across key metrics. Fourth quarter collections rose to
Estimated remaining collections reached
For full year 2025, total revenues increased to
Recent developments include the closing of the Bluestem portfolio purchase on
Jefferson Capital, Inc. disclosed that investor David M. Burton beneficially owned 3,777,500 shares of its common stock as of June 30, 2025, representing 5.8% of the outstanding shares based on 64,685,082 shares then outstanding. Burton had sole voting and dispositive power over these shares.
The filing notes that 385,000 shares of common stock were sold on January 9, 2026, after which Burton’s beneficial ownership decreased to 5.5% of Jefferson Capital’s outstanding common stock, based on 61,629,228 shares outstanding as of January 8, 2026. The position is held directly in Burton’s name, and no group or additional controlling entities are identified.
Jefferson Capital, Inc. director and Chief Executive Officer and President David M. Burton reported a sale of common stock. On January 9, 2026, he sold 385,000 shares of Jefferson Capital common stock at $20.50 per share, coded as an open market or similar sale ("S").
According to the footnote, this represents the sale of shares to the underwriters in the issuer's secondary offering, rather than ordinary open-market trading. After this transaction, Burton beneficially owned 3,392,500 shares of Jefferson Capital common stock in direct form.